Janssen Biotech, Inc. v. Amgen Inc.
| Janssen Biotech, Inc. |
| Amgen Inc. |
| 1:2022cv01549 |
| November 29, 2022 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 23, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 13
SO ORDERED WITH MODIFICATIONS re #12 Stipulation and Order Regarding Amended Complaint and Response. Signed by Judge Maryellen Noreika on 1/23/2023. (dlw)
|
| Filing 12 STIPULATION and [Proposed] Order Regarding Amended Complaint and Response by Amgen Inc.. (Mowery, Katharine) |
|
Filing 11
SO ORDERED re #9 Stipulation Regarding Agreement as to U.S. Patent No. 6,902,734 (B2). Signed by Judge Maryellen Noreika on 1/23/2023. (dlw) (dlw).
|
| Filing 10 PROPOSED ORDER to Stipulation Regarding As To US Patent No. 6,902,734 (B2)t re #9 Stipulation by Amgen Inc.. (Mowery, Katharine) |
| Filing 9 [SEALED] STIPULATION Regarding Agreement As To US Patent No. 6,902,734 (B2) by Amgen Inc.. (Mowery, Katharine) |
| CORRECTING ENTRY: The signed Order has been uploaded to D.I. 11 and the NEF regenerated. (dlw) |
| Filing 8 STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to January 23, 2023 - filed by Amgen Inc.. (Whetzel, Robert) |
|
SO ORDERED re #8 STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to January 23, 2023 (Set/Reset Answer Deadlines: Amgen Inc. answer due 1/23/2023). ORDERED by Judge Maryellen Noreika on 12/20/2022. (dlw)
|
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Michael A. Morin, David P. Frazier, Inge A. Osman, Cecilia Sanabria, Michael Seringhaus, and Gabrielle LaHatte - filed by Janssen Biotech, Inc.. (Joyce, Alexandra) |
|
SO ORDERED re #7 MOTION for Pro Hac Vice Appearance of Attorney Michael A. Morin, David P. Frazier, Inge A. Osman, Cecilia Sanabria, Michael Seringhaus, and Gabrielle LaHatte filed by Janssen Biotech, Inc. ORDERED by Judge Maryellen Noreika on 12/14/2022. (dlw)
|
| Pro Hac Vice Attorney Michael R. Seringhaus and Inge A. Osman for Janssen Biotech, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 6 SUMMONS Returned Executed by Janssen Biotech, Inc..Amgen Inc. served on 12/1/2022, answer due 12/22/2022. (Silver, Daniel) |
| Filing 5 Summons Issued as to Amgen Inc. on 11/30/2022. (vfm) |
| Filing 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc. filed by Janssen Biotech, Inc.. (vfm) |
| Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,902,734 ;10,961,307. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Amgen Inc. ( Filing fee $ 402, receipt number ADEDC-4014567.) - filed by Janssen Biotech, Inc.. (Attachments: #1 Exhibit A-G, #2 Exhibit H-N, #3 Civil Cover Sheet) (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
